• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Inhibition of LINGO1 as a therapeutic target to promote axonal regeneration and repair for neurological disorders.抑制LINGO1作为促进轴突再生和修复神经疾病的治疗靶点。
3 Biotech. 2023 Nov;13(11):372. doi: 10.1007/s13205-023-03789-4. Epub 2023 Oct 16.
2
LINGO-1 and AMIGO3, potential therapeutic targets for neurological and dysmyelinating disorders?LINGO-1和AMIGO3,神经疾病和脱髓鞘疾病的潜在治疗靶点?
Neural Regen Res. 2017 Aug;12(8):1247-1251. doi: 10.4103/1673-5374.213538.
3
Virtual screening of acetylcholinesterase inhibitors through pharmacophore-based 3D-QSAR modeling, ADMET, molecular docking, and MD simulation studies.通过基于药效团的3D-QSAR建模、ADMET、分子对接和分子动力学模拟研究对乙酰胆碱酯酶抑制剂进行虚拟筛选。
In Silico Pharmacol. 2024 Feb 17;12(1):13. doi: 10.1007/s40203-024-00189-1. eCollection 2024.
4
The potential of LINGO-1 as a therapeutic target for essential tremor.LINGO-1作为特发性震颤治疗靶点的潜力。
Expert Opin Ther Targets. 2015;19(8):1139-48. doi: 10.1517/14728222.2015.1028360. Epub 2015 Apr 10.
5
Insight parameter drug design for human β-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of α-keto-[1,2,4]-oxadiazoles.α-酮-[1,2,4]-噁二唑类化合物的分子对接、QSAR、分子动力学模拟和药效团建模研究对人β-胰凝乳蛋白酶抑制的深入参数药物设计。
J Biomol Struct Dyn. 2023;41(22):12978-12996. doi: 10.1080/07391102.2023.2171131. Epub 2023 Jan 29.
6
An insight into selective and potent inhibition of histone deacetylase 8 through induced-fit docking, pharmacophore modeling and QSAR studies.通过诱导契合对接、药效团建模和定量构效关系研究深入了解组蛋白去乙酰化酶 8 的选择性和高效抑制作用。
J Biomol Struct Dyn. 2020 Jan;38(1):48-65. doi: 10.1080/07391102.2019.1567388. Epub 2019 Feb 7.
7
Identification of coumarin derivatives targeting acetylcholinesterase for Alzheimer's disease by field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, MM/GBSA, ADME and MD Simulation study.基于场的3D-QSAR、基于药效团模型的虚拟筛选、分子对接、MM/GBSA、ADME和分子动力学模拟研究鉴定用于阿尔茨海默病的靶向乙酰胆碱酯酶的香豆素衍生物
Curr Res Struct Biol. 2024 Jan 7;7:100124. doi: 10.1016/j.crstbi.2024.100124. eCollection 2024.
8
Increased LINGO1 in the cerebellum of essential tremor patients.原发性震颤患者小脑内LINGO1增加。
Mov Disord. 2014 Nov;29(13):1637-47. doi: 10.1002/mds.25819. Epub 2014 Feb 14.
9
Unveiling critical structural features for effective HDAC8 inhibition: a comprehensive study using quantitative read-across structure-activity relationship (q-RASAR) and pharmacophore modeling.揭示有效 HDAC8 抑制的关键结构特征:使用定量读片结构-活性关系(q-RASAR)和药效团建模的综合研究。
Mol Divers. 2024 Aug;28(4):2197-2215. doi: 10.1007/s11030-024-10903-y. Epub 2024 Jun 13.
10
3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.抗结核药物(6S)2-硝基-6-{[4-(三氟甲氧基)苄基]氧基}-6,7-二氢-5H-咪唑并[2,1-b][1,3]恶嗪延长侧链的3D QSAR、对接、分子动力学模拟及MM-GBSA研究
Infect Disord Drug Targets. 2019;19(2):145-166. doi: 10.2174/1871526518666181015145545.

引用本文的文献

1
Exploring therapeutic potential of bioactive compounds against Alzheimer's and Parkinson's diseases.探索生物活性化合物对阿尔茨海默病和帕金森病的治疗潜力。
3 Biotech. 2025 Mar;15(3):61. doi: 10.1007/s13205-025-04224-6. Epub 2025 Feb 14.
2
An In Silico Study on Withania somnifera Bioactives and Curcumin Analogs as Potential Inducers of Smoothened (Smo) Receptor of Sonic Hedgehog (SHH) Pathway to Promote Oligodendrogenesis.一项关于睡茄生物活性成分和姜黄素类似物作为音猬因子(SHH)信号通路中平滑受体(Smo)潜在诱导剂以促进少突胶质细胞生成的计算机模拟研究。
Mol Neurobiol. 2025 Mar;62(3):3523-3543. doi: 10.1007/s12035-024-04489-7. Epub 2024 Sep 21.

本文引用的文献

1
Axonal growth inhibitors and their receptors in spinal cord injury: from biology to clinical translation.脊髓损伤中的轴突生长抑制剂及其受体:从生物学到临床转化
Neural Regen Res. 2023 Dec;18(12):2573-2581. doi: 10.4103/1673-5374.373674.
2
Therapeutical growth in oligodendroglial fate induction via transdifferentiation of stem cells for neuroregenerative therapy.通过干细胞转分化诱导少突胶质细胞命运用于神经再生治疗的治疗性生长。
Biochimie. 2023 Aug;211:35-56. doi: 10.1016/j.biochi.2023.02.012. Epub 2023 Feb 25.
3
Modulation of GPCR receptors common to gut inflammatory diseases and neuronal disorders, Alzheimer's and Parkinson's diseases as druggable targets through bioactives: an study.通过生物活性物质调节肠道炎症性疾病和神经紊乱、阿尔茨海默病和帕金森病共有的 GPCR 受体作为可药物靶点:一项研究。
J Biomol Struct Dyn. 2023 Jul;41(10):4485-4503. doi: 10.1080/07391102.2022.2068072. Epub 2022 May 1.
4
Evaluation of phytoconstituents of against K417N and N501Y mutant spike glycoprotein and main protease of SARS-CoV-2- an in silico study.抗 SARS-CoV-2 的 K417N 和 N501Y 突变刺突糖蛋白和主要蛋白酶的植物成分评价 - 一项计算机研究。
J Biomol Struct Dyn. 2023 Jun;41(9):4106-4123. doi: 10.1080/07391102.2022.2062787. Epub 2022 Apr 25.
5
Potential Role of Growth Factors Controlled Release in Achieving Enhanced Neuronal Trans-differentiation from Mesenchymal Stem Cells for Neural Tissue Repair and Regeneration.生长因子控释在促进间充质干细胞向神经元转分化以实现神经组织修复和再生中的潜在作用。
Mol Neurobiol. 2022 Feb;59(2):983-1001. doi: 10.1007/s12035-021-02646-w. Epub 2021 Nov 24.
6
Regulation of neuronal repair and regeneration through inhibition of oligodendrocyte myelin glycoprotein (OMgp).通过抑制少突胶质细胞髓鞘糖蛋白(OMgp)来调节神经元修复和再生。
J Biomol Struct Dyn. 2022;40(24):13936-13952. doi: 10.1080/07391102.2021.1997820. Epub 2021 Nov 17.
7
Network pharmacological evaluation of bioactive phytochemicals for identifying novel potential inhibitors against neurodegenerative disorder.网络药理学评价生物活性植物化学物质,以鉴定新型潜在抑制剂对抗神经退行性疾病。
J Biomol Struct Dyn. 2022;40(21):10887-10898. doi: 10.1080/07391102.2021.1951355. Epub 2021 Jul 19.
8
Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro.通过抑制 SARS-CoV-2 Mpro 来探索具有抗 SARS-CoV-2 活性的天然化合物。
Brief Bioinform. 2021 Mar 22;22(2):1361-1377. doi: 10.1093/bib/bbaa382.
9
Therapeutic Advancement in Neuronal Transdifferentiation of Mesenchymal Stromal Cells for Neurological Disorders.间质干细胞向神经细胞转分化在神经紊乱治疗中的进展。
J Mol Neurosci. 2021 May;71(5):889-901. doi: 10.1007/s12031-020-01714-5. Epub 2020 Oct 13.
10
Demyelination contributes to depression comorbidity in a rat model of chronic epilepsy via dysregulation of Olig2/LINGO-1 and disturbance of calcium homeostasis.脱髓鞘通过调节少突胶质细胞转录因子 2/神经生长抑制因子 1 和破坏钙稳态导致慢性癫痫大鼠模型中抑郁共病。
Exp Neurol. 2019 Nov;321:113034. doi: 10.1016/j.expneurol.2019.113034. Epub 2019 Aug 12.

抑制LINGO1作为促进轴突再生和修复神经疾病的治疗靶点。

Inhibition of LINGO1 as a therapeutic target to promote axonal regeneration and repair for neurological disorders.

作者信息

Atta Avik, Gupta Ayushi, Choudhary Princy, Dwivedi Shrey, Singh Sangeeta

机构信息

Applied Science Department, Indian Institute of Information Technology, Allahabad, Devghat, Jhalwa, Prayagraj, 211015 Uttar Pradesh India.

出版信息

3 Biotech. 2023 Nov;13(11):372. doi: 10.1007/s13205-023-03789-4. Epub 2023 Oct 16.

DOI:10.1007/s13205-023-03789-4
PMID:37854938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10579209/
Abstract

UNLABELLED

The Central nervous system is blemished by the high incidence of neurodegenerative diseases, which is known to cause disfiguration of regeneration and repair of axonal growth. Recognition of proteins that act as agents of repressing such repair has become the norm to tackle these abominable conditions. One such protein is LINGO1 that act as a repressor for axonal growth. Being one of the critical causative agents of several neurodegenerative pathways. Consequently, its inhibition may tend to help the outcomes of regenerative technologies aiming to outweigh the symptoms of neurodegenerative diseases. For this objective, LINGO1 was targeted with pharmacophore analogs of Fasudil and Ibuprofen, as they are known to have a deterring effect against the concerned protein. 1-Tosyl-2-(chloromethyl)-2,3-dihydro-1H-indole was found showing the least binding score of - 6.8, with verified ADMET admissibility. The pharmacological activity of the said ligand was estimated with QSAR tool showing favourable electro-steric model. All this was finally collaborated with a molecular dynamics simulation study which exhibited a stable structure compatibility of the ligand with LINGO-1. Further, the efficacy of the compound can be evaluated through experimental studies for inferring its future potential and utilization as an effective means to tackle neuronal regeneration and remyleination.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s13205-023-03789-4.

摘要

未标记

中枢神经系统因神经退行性疾病的高发病率而存在缺陷,已知这些疾病会导致轴突生长的再生和修复出现畸形。识别作为抑制这种修复作用因子的蛋白质已成为应对这些恶劣状况的常态。一种这样的蛋白质是LINGO1,它作为轴突生长的抑制剂。它是几种神经退行性通路的关键致病因素之一。因此,抑制它可能有助于旨在减轻神经退行性疾病症状的再生技术取得更好效果。为了这个目标,用法舒地尔和布洛芬的药效团类似物靶向LINGO1,因为已知它们对相关蛋白质有抑制作用。发现1-对甲苯磺酰基-2-(氯甲基)-2,3-二氢-1H-吲哚的结合分数最低,为-6.8,且具有经验证的药物代谢动力学和毒性性质可接受性。用定量构效关系工具评估了所述配体的药理活性,显示出有利的电子立体模型。所有这些最终与分子动力学模拟研究相结合,该研究展示了配体与LINGO-1的稳定结构相容性。此外,该化合物的功效可通过实验研究进行评估,以推断其未来潜力以及作为解决神经元再生和髓鞘再生的有效手段的用途。

补充信息

在线版本包含可在10.1007/s13205-023-03789-4获取的补充材料。